-SEC FIling
PerkinElmer Sees Q4 Adj. EPS $2.40+ vs $2.12 Est., Sees COVID-Related Revenues ~$320M
Fourth quarter 2021 revenue and earnings per share to exceed prior guidance
Non-COVID organic growth in fourth quarter 2021 of approximately 10%
Fourth quarter 2021 COVID product and